| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bbd02220f0cd581bb20aeb24e6f05f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d8035112a71acbb853d4c6cb1eb5b1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d49fc0d6065e218a3216ad68b100de2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1174ce1fb9f3d7fe82c3fee5468cef8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d0af88aad0cffb632b774a666e57f76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13be81eac4b32b982b69bd4198d9e088 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2261-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-664 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8f1104bccb94d7d59fd8283299c5e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7076d1601464be0c502fa3dbc4d859c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1562eeef6b80e47c4aa44e2d9c8fd2d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3da86ba01b01d3f1731b6b84ab44df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1952ba5ecd7eee2e59de5b4ff7d88144 |
| publicationDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007109303-A2 |
| titleOfInvention |
Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| abstract |
Therapeutic formulations comprising an effective amount of IL-2 or other lymphokine and a biodegradable polymeric carrier having reverse gelation properties and the methods of use thereof for local or both local and systemic control of proliferative cell disorders is disclosed. The formulation can be administered intratumorally/peritumorally and forms an IL-2 containing depot. The IL-2-containing depot provides for continuous, prolonged release of IL-2 sufficient to stimulate the production of cytotoxic T lymphocytes which function both locally and systemically, without causing unacceptable side effects. |
| priorityDate |
2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |